← Insiders

AGPU

Neutral signalScored 2026-09-10 Drivers: fundamentals. Moteurs : fondamentaux.

Research, not advice.

À propos

Axe Compute Inc.

Nom
Axe Compute Inc.
Secteur
Technology
Industrie
Software - Infrastructure
Bourse
NASDAQ
Capitalisation
$85.3M
Employés
14
PDG
Christopher Miglino
Site web
https://axecompute.com
Marché
AIMAMIXBNGOCYCNGBSHSCS

Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

ACHAT TOTAL: 8 750 titres (~95 156,25 $ US)

Insiders
Zhu Theodore
Total bought
$95,156

Avg buy (VWAP, 90d window) $11.72 vs last close —

Total sold
—

Avg sell (VWAP, 90d window) —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
2026-09-08
Last synced
2026-09-14 09:51:34 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-09-08 Zhu Theodore Buy · P 3,750 $11.72 $43,950 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Signal

Neutral signalScored 2026-09-10 Drivers: fundamentals. Moteurs : fondamentaux.

AGPU presents a striking divergence: a powerful short-term earnings catalyst (90x sequential revenue growth, $2.8B+ contracts, insider buying) collides head-on with catastrophic fundamentals, including -1860% net…

The first sentence of the analysis written for AGPU on 2026-09-10 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: fundamentals. Moteurs : fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Supports a bullish reading. Open-market purchases outweigh sales
  • Congress Unavailable or mixed. No purchase disclosures in the stored window
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Timing Unavailable or mixed. No stored price series
  • Financial indicators Unavailable or mixed. Current ratio 10.02 · operating margin -22689% — readings disagree

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin42.0%49.1%62.6%66.4%65.7%
Ebit Margin-185860.6%-668.8%-738.3%-1014.2%-948.2%
Ebitda Margin-185311.0%-626.0%-723.3%-926.9%-853.9%
Operating Profit Margin-22688.6%-673.7%-744.5%-1729.3%-1437.9%
Pretax Profit Margin-185860.6%-668.8%-738.3%-1709.6%-1430.2%
Continuous Operations Profit Margin-185860.6%-668.8%-738.3%-1709.6%-1383.6%
Net Profit Margin-186053.4%-751.4%-859.1%-1709.6%-1383.6%
Bottom Line Profit Margin-186053.4%-751.4%-738.3%-1709.6%-1383.6%
Current Ratio10.0240.6192.5516.0169.091
Quick Ratio10.0240.5122.4295.9068.971
Solvency Ratio-44.941-2.223-2.236-6.154-5.225
Cash Ratio2.5290.2042.2095.6858.703
Price To Earnings Ratio-0.535-5.491-14.181-13.178-39.884
Price To Earnings Growth Ratio-0.0010.1540.2835.2420.476
Forward Price To Earnings Growth Ratio-0.0010.1540.2835.2420.476
Price To Earnings Diluted Ratio-0.535-5.491-14.181-13.178-39.663
Price To Earnings Diluted Growth Ratio-0.0010.1540.2834.3130.474
Price To Book Ratio2.612-331.07723.95315.57619.363
Price To Sales Ratio994.72841.310121.726225.203548.789
Price To Free Cash Flow Ratio-2.933-5.606-14.998-26.391-59.194
Price To Operating Cash Flow Ratio-12.514-5.611-15.022-27.406-63.859
Debt To Assets Ratio0.0320.4290.1890.0070.020
Debt To Equity Ratio0.035-10.5180.3300.0080.022
Debt To Capital Ratio0.0341.1050.2480.0080.021
Long Term Debt To Capital Ratio0.0000.0000.0000.0000.000
Financial Leverage Ratio1.108-24.5421.7431.1821.087
Working Capital Turnover Ratio0.0070.6820.1270.0660.154
Operating Cash Flow Ratio-2.334-3.327-3.338-3.186-3.768
Operating Cash Flow Sales Ratio-79.488-7.363-8.103-8.217-8.594
Free Cash Flow Operating Cash Flow Ratio4.2671.0011.0021.0381.079
Debt Service Coverage Ratio-2,150.6520.000-78.272-1.3100.000
Interest Coverage Ratio0.0000.0000.000-2.4440.000
Short Term Operating Cash Flow Coverage Ratio-92.2510.000-87.6910.0000.000
Operating Cash Flow Coverage Ratio-5.977-5.610-4.838-68.605-13.884
Capital Expenditure Coverage Ratio-0.305-1,257.301-612.634-26.006-12.687
Dividend Paid And Capex Coverage Ratio-0.305-1,257.301-612.634-26.006-12.687
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple-0.497-6.737-16.320-22.727-62.016

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 42.0% ▼-7.1% ▼-15.2%
Ebit Margin -185860.6% ▼-185191.8% ▼-148014.6%
Ebitda Margin -185311.0% ▼-184685.1% ▼-147622.8%
Operating Profit Margin -22688.6% ▼-22014.9% ▼-17233.8%
Pretax Profit Margin -185860.6% ▼-185191.8% ▼-147779.1%
Continuous Operations Profit Margin -185860.6% ▼-185191.8% ▼-147788.4%
Net Profit Margin -186053.5% ▼-185302.1% ▼-147902.0%
Bottom Line Profit Margin -186053.5% ▼-185302.1% ▼-147926.2%
Current Ratio 10.024 ▲9.404 ▲4.364
Quick Ratio 10.024 ▲9.512 ▲4.455
Solvency Ratio -44.941 ▼-42.718 ▼-32.785
Cash Ratio 2.529 ▲2.325 ▼-1.337
Price To Earnings Ratio -0.535 ▲4.956 ▲14.119
Price To Earnings Growth Ratio -0.001 ▼-0.155 ▼-1.232
Forward Price To Earnings Growth Ratio -0.001 ▼-0.155 ▼-1.232
Price To Earnings Diluted Ratio -0.535 ▲4.956 ▲14.075
Price To Earnings Diluted Growth Ratio -0.001 ▼-0.155 ▼-1.046
Price To Book Ratio 2.612 ▲333.689 ▲56.526
Price To Sales Ratio 994.728 ▲953.418 ▲608.377
Price To Free Cash Flow Ratio -2.933 ▲2.673 ▲18.892
Price To Operating Cash Flow Ratio -12.514 ▼-6.904 ▲12.368
Debt To Assets Ratio 0.032 ▼-0.397 ▼-0.104
Debt To Equity Ratio 0.035 ▲10.553 ▲2.059
Debt To Capital Ratio 0.034 ▼-1.071 ▼-0.249
Long Term Debt To Capital Ratio 0.000 0.000 0.000
Financial Leverage Ratio 1.108 ▲25.651 ▲4.993
Working Capital Turnover Ratio 0.007 ▼-0.675 ▼-0.201
Operating Cash Flow Ratio -2.334 ▲0.993 ▲0.857
Operating Cash Flow Sales Ratio -79.488 ▼-72.125 ▼-57.135
Free Cash Flow Operating Cash Flow Ratio 4.267 ▲3.266 ▲2.590
Debt Service Coverage Ratio -2150.652 ▼-2150.652 ▼-1704.605
Interest Coverage Ratio 0.000 0.000 ▲0.489
Short Term Operating Cash Flow Coverage Ratio -92.251 ▼-92.251 ▼-56.263
Operating Cash Flow Coverage Ratio -5.977 ▼-0.366 ▲13.806
Capital Expenditure Coverage Ratio -0.305 ▲1256.995 ▲381.481
Dividend Paid And Capex Coverage Ratio -0.305 ▲1256.995 ▲381.481
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple -0.497 ▲6.239 ▲21.162

Key metrics

MetricTrend20252024202320222021
Market cap$124.6M$67.1M$198.1M$339.0M$779.7M
Enterprise value$115.5M$68.5M$192.1M$317.1M$752.3M
EV / Sales921.90x42.17x118.04x210.66x529.56x
EV / Op. cash flow-11.60x-5.73x-14.57x-25.64x-61.62x
EV / Free cash flow-2.72x-5.72x-14.54x-24.69x-57.12x
EV / EBITDA-0.50x-6.74x-16.32x-22.73x-62.02x
Net debt / EBITDA0.04x-0.14x0.51x1.57x2.25x
Current ratio10.02x0.62x2.55x6.02x9.09x
Income quality0.04x1.10x1.10x0.48x0.62x
Graham net-net$1-$1$1$5$9
Tax burden100.1%112.3%116.4%100.0%96.7%
Interest burden100.0%100.0%100.0%168.6%150.8%
Working capital$38.5M-$1.4M$6.1M$19.5M$26.2M
Invested capital$40.2M$1.3M$10.3M$21.8M$40.4M
Return on assets-440.7%-245.4%-97.0%-100.0%-44.9%
Operating ROA-98.3%-112.8%-60.4%-74.9%-71.9%
Return on tangible assets-440.7%-256.2%-98.7%-101.0%-59.7%
Return on equity-488.5%6022.0%-169.1%-118.2%-48.8%
Return on invested capital-57.6%-560.5%-109.5%-118.6%-48.0%
Return on capital employed-58.5%-793.2%-115.8%-119.1%-50.4%
Earnings yield-187.0%-18.2%-7.1%-7.6%-2.5%
Free cash flow yield-34.1%-17.8%-6.7%-3.8%-1.7%
Capex / Op. cash flow-327.5%-0.1%-0.2%-3.8%-7.9%
Capex / Depreciation4736.9%1.4%3.0%36.2%71.8%
Capex / Sales26034.3%0.6%1.3%31.6%67.7%
SG&A / Sales21016.7%547.2%556.4%828.3%824.0%
R&D / Sales1713.9%1.6%7.5%21.3%22.2%
Stock comp / Sales0.0%0.0%0.0%34.7%64.8%
Intangibles / Total assets0.0%4.2%1.8%1.0%24.7%
Days sales outstanding21147d168d62d80d91d
Days payables outstanding9251d505d799d682d766d
Operating cycle21147d338d350d391d382d
Cash conversion cycle11896d-167d-449d-290d-384d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▲+85.8%EV / Sales ▲+2086.2%EV / EBITDA ▲+92.6%EV / Op. cash flow ▼-5.870Earnings yield ▼-1.689
Profitability
Return on equity ▼-65.105Return on assets ▼-1.954Return on invested capital ▲+5.029Return on capital employed ▲+7.348Operating ROA ▲+0.146Income quality ▼-1.058Tax burden ▼-0.122
Efficiency
Days sales outstanding ▲+20979.464Days payables outstanding ▲+8745.983Operating cycle ▲+20809.043Cash conversion cycle ▲+12063.060Capex / Sales ▲+260.337R&D / Sales ▲+17.123
Balance-sheet strength
Current ratio ▲+9.404Net debt / EBITDA ▲+0.177Working capital ▲+39870534.000Invested capital ▲+38937275.000Intangibles / Total assets ▼-0.042

Change over 5 years

Valuation
Market cap ▼-84.0%EV / Sales ▲+74.1%EV / EBITDA ▲+99.2%EV / Op. cash flow ▲+50.023Earnings yield ▼-1.845
Profitability
Return on equity ▼-4.397Return on assets ▼-3.958Return on invested capital ▼-0.096Return on capital employed ▼-0.081Operating ROA ▼-0.264Income quality ▼-0.578Tax burden ▲+0.034
Efficiency
Days sales outstanding ▲+21056.052Days payables outstanding ▲+8485.174Operating cycle ▲+20765.502Cash conversion cycle ▲+12280.328Capex / Sales ▲+259.666R&D / Sales ▲+16.917
Balance-sheet strength
Current ratio ▲+0.933Net debt / EBITDA ▼-2.213Working capital ▲+12285286.000Invested capital ▼-149815.000Intangibles / Total assets ▼-0.247

Employee count

Peer market caps

Recent news